We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NESN:SIXNestle S.A. Analysis

Data as of 2026-08-01 - not real-time

CHF 81.01

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The 20‑day moving average sits above the 50‑day average, confirming a short‑term bullish bias, while the 200‑day average remains lower, supporting the longer‑term uptrend. RSI hovers in the neutral zone, indicating no extreme overbought or oversold pressure, but the MACD histogram is negative, hinting at a near‑term bearish pullback. Volume is on the rise, which adds credibility to the current price action. Valuation & fundamentals: The current price trades below consensus target levels, implying modest upside potential. A forward price‑to‑earnings multiple well below the trailing multiple points to a valuation compression ahead. The dividend yield is appealing, yet the payout ratio exceeds earnings, raising questions about sustainability. Robust operating cash flow and free cash flow generation underpin the balance sheet despite a slight revenue dip, and return on equity remains strong. Risk considerations: Extremely low beta suggests minimal market‑wide volatility exposure, but 30‑day price volatility is relatively high, reflecting notable price swings. The defensive consumer sector and diversified geographic footprint temper sector‑specific risks, while regulatory and currency exposures remain moderate. Overall, the stock appears positioned for a gradual recovery with upside potential for patient investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish moving‑average alignment
  • Increasing trading volume
  • MACD bearish divergence suggesting short‑term caution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Target price consensus indicating ~10% upside
  • Strong cash‑flow generation supporting dividend and buybacks
  • Defensive sector positioning with stable margins

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Resilient global brand portfolio
  • Consistently high return on equity
  • Undervalued relative to forward earnings multiple

Key Metrics & Analysis

Financial Health

Revenue Growth-2.50%
Profit Margin8.38%
P/E Ratio28.5
ROE26.24%
ROA6.65%
Debt/Equity213.00
P/B Ratio6.4
Op. Cash FlowCHF16.4B
Free Cash FlowCHF4.4B

Technical Analysis

TrendBullish
RSI45.1
SupportCHF 79.12
ResistanceCHF 87.09
MA 20CHF 83.32
MA 50CHF 81.37
MA 200CHF 79.17
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88

Valuation

Target PriceCHF 88.87
Upside/Downside9.71%
GradeUndervalued
TypeValue
Dividend Yield3.76%

Risk Assessment

Beta0.04
Volatility32.31%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.